Domainex's newsletter brings you up to speed on the latest announcements from the team.
No images? Click here
Domainex newsletter
All the latest news and industry insights from the Domainex team
Tom Mander, CEO
Attending events and enriching the team
We’re over halfway through the year and, with all the projects and events our team have been busy with, it’s flown by! One of these exciting projects is our collaboration with NRG Therapeutics for their Biomedical Catalyst funded Parkinson’s disease project. We’ve been making the most of getting out in the field by attending a number of recent events, such as OBN BioTuesday at the Rosalind Franklin Institute.
As well as events, we’ve been focused on further enriching our team through the appointment of new members of staff, including Dr Scott Martin as Analytical and Bioanalytical Group Leader, and initiating company-wide training programmes. I look forward to seeing how attending industry events and investing in our team will benefit new and existing projects over the coming months.
Thanks to everyone in our expanding team for their excellent work so far this year.
NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project
Domainex and NRG Therapeutics have announced a collaboration focused on developing novel small molecule disease-modifying medicines for the treatment of Parkinson's disease, motor neurone disease (MND) and other debilitating chronic neurodegenerative disorders. Domainex will provide fully integrated lead optimisation services including assay biology and medicinal and computational chemistry.
Domainex appoints Dr Scott Martin as Analytical and Bioanalytical Group Leader
Dr Martin has 25 years of experience in bioanalytical/analytical mass spectrometry within drug discovery and development, predominately gained in large pharma. This wealth of experience will be invaluable in further strengthening the analytical chemistry and bioanalytical team.
Domainex initiates company-wide training programmes
We have recently extended our training programmes to both enhance our technical skills and better equip our leaders for the new opportunities we see ahead of us.
Meet the Domainex Team: Nima Abbasian
Nima Abbasian, Senior Scientist, Assay Biologist, at Domainex tells us about his journey through his career, from completing his PhD through to his role today, with insights into his out-of-work passions for literature, history and travel.
OBN BioTuesday at the Rosalind Franklin Institute
The Rosalind Franklin Institute opened its doors to the OBN community by hosting a showcase and networking evening.
8th RSC-BMCS Fragment-based Drug Discovery
Domainex was represented by several members of the team at the 8th RSC-BMCS Fragment-based Drug Discovery meeting at Churchill College, Cambridge, UK.
A Talk by Professor Marcus Baumann — Continuous Flow Synthesis
Our ‘Science and Snacks’ events have recommenced with a talk by Professor Marcus Baumann. The idea of these events is to invite guest speakers to share the latest developments in scientific hot topics, followed by a buffet of snacks.
In other news…
CEO of Creoptix AG, Line Stigen Raquet, visited our Biology Centre of Excellence. We’ve also ordered two important new pieces of equipment to add to our biology service platform — a flow cytometer from Miltenyi Biotec and a CERTUS FLEX digital dispenser from Gyger AG.
New recruits
Welcome to Daniel Membere (Scientist, Assay Biology), David Gibson (Senior Scientist I, Chemistry), Laura Lemel (Senior Scientist I, Assay Biology), Melinda Morelli (Senior Scientist I, Chemistry), Natasha Pretot (Laboratory Technician), Nathan Zaccai (Associate Principal Scientist, Protein Science) and Tim Nash (Scientist, Chemistry) who have all recently joined the Domainex team. If you are interested in joining these new members of staff at Domainex, visit our website to view the current available opportunities.
Upcoming events
XXVll EFMC International Symposium on Medicinal Chemistry
4th-8th September 2022 | Nice, France
Covering advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases, and cancer.
17th Drug Discovery Innovation Programme
13th-14th September 2022 | Munich, Germany
Including top-level strategic content, current scientific insights, networking, and discussions from leading global pharmaceutical R&D executives.
Discovery on Target
17th-18th October 2022 | Boston, United States
Highlighting advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.
